A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression-Reference-Cited by-同舟云学术

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression

Published:2023-05 Issue:5 Volume:41 Page:986-1002.e9
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Hutten Stefan J.,de Bruijn Roebi,Lutz Catrin,Badoux Madelon,Eijkman Timo,Chao Xue,Ciwinska Marta,Sheinman Michael,Messal Hendrik,Herencia-Ropero Andrea,Kristel Petra,Mulder Lennart,van der Waal Rens,Sanders Joyce,Almekinders Mathilde M.,Llop-Guevara Alba,Davies Helen R.,van Haren Matthijs J.,Martin Nathaniel I.,Behbod Fariba,Nik-Zainal Serena,Serra Violeta,van Rheenen Jacco,Lips Esther H.,Wessels Lodewyk F.A.,Wesseling Jelle,Scheele Colinda L.G.J.,Jonkers Jos^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference80 articles.

1. Netherlands Comprehensive Cancer Organisation. (2016). www.cijfersoverkanker.nl.

2. Cancer statistics, 2020;Siegel;CA A Cancer J. Clin.,2020

3. Ductal carcinoma in situ: to treat or not to treat, that is the question;van Seijen;Br. J. Cancer,2019

4. Copy number analysis of ductal carcinoma in situ with and without recurrence;Gorringe;Mod. Pathol.,2015

5. Whole-exome sequencing analysis of the progression from non–low-grade ductal carcinoma in situ to invasive ductal carcinoma;Pareja;Clin. Cancer Res.,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma;Breast Cancer Research;2024-08-13

2. Genomic profiling of a multi-lineage and multi-passage patient-derived xenograft biobank reflects heterogeneity of ovarian cancer;Cell Reports Medicine;2024-07

3. Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment;The Lancet;2024-06

4. Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts;The Journal of Pathology;2024-05-23

5. Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer;2023-12-13